Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Artificial Intelligence-Assisted Endoscopic Ultrasound-Guided Ablation of Pancreatic Neuroendocrine Tumors: Toward Precision Diagnosis, Risk Stratification, and Personalized Therapy.

Cureus·2026

Same author

Microperimetry as an Outcome Measure Improves Patient Eligibility and Efficacy Detection in RPGR Gene Therapy Trials.

American journal of ophthalmology·2026

Same author

Efficacy of anti-VEGF single-chain variable fragment AAV-based gene therapy in a laser-induced choroidal neovascularisation mouse model.

Molecular therapy. Advances·2026

Same author

Clinical Significance and Long-Term Prognosis of Appendiceal Orifice Inflammation in Ulcerative Colitis: A Systematic Review.

Cureus·2026

Same author

Optogenetics for therapeutic use in the brain, eye, and ear.

Handbook of clinical neurology·2026

Same author

The prevalence of neck pain and its association with studying device usage and posture among students at the University of Jordan: A cross-sectional study.

PloS one·2026

Same journal

Artificial intelligence-driven multi-omics analysis of gut-kidney axis in chronic kidney disease.

Progress in molecular biology and translational science·2026

Same journal

Artificial intelligence in multi-omics analysis of heart diseases.

Progress in molecular biology and translational science·2026

Same journal

AI in multi-omics analysis of type 2 diabetes.

Progress in molecular biology and translational science·2026

Same journal

AI in multi-omics analysis in AMR.

Progress in molecular biology and translational science·2026

Same journal

AI in multi-omics analysis of COVID-19 patient data.

Progress in molecular biology and translational science·2026

Same journal

AI in multi-omics analysis of liver diseases.

Progress in molecular biology and translational science·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Nov 1, 2025

Author Spotlight: Exploring Retinal Regeneration Mechanisms in the Xenopus Frog

Author Spotlight: Exploring Retinal Regeneration Mechanisms in the Xenopus Frog

Published on: October 13, 2023

CRISPR genome engineering for retinal diseases.

Ariel Kantor¹, Michelle E McClements¹, Caroline F Peddle¹

¹Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences & NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.

Progress in Molecular Biology and Translational Science

|June 27, 2021

Summary

This summary is machine-generated.

CRISPR gene editing offers new hope for treating inherited retinal diseases. This technology can precisely target genetic defects, advancing therapies for previously untreatable blinding conditions.

Keywords:

Adeno-associated vector CRISPR/Cas Gene therapy Genome engineering Inherited retinal disease Retina

More Related Videos

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

Related Experiment Videos

Last Updated: Nov 1, 2025

Author Spotlight: Exploring Retinal Regeneration Mechanisms in the Xenopus Frog

Author Spotlight: Exploring Retinal Regeneration Mechanisms in the Xenopus Frog

Published on: October 13, 2023

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

Area of Science:

Ophthalmology
Genetics
Biotechnology

Background:

Inherited retinal diseases are a leading cause of blindness with limited therapeutic options.
Gene therapy has emerged as a promising approach for treating these conditions.
CRISPR gene editing technology has revolutionized the potential for genetic interventions.

Purpose of the Study:

To review the CRISPR gene editing toolkit.
To discuss current and future applications of CRISPR for inherited retinal diseases.
To highlight the potential of CRISPR in treating blinding conditions.

Main Methods:

Review of CRISPR-Cas gene editing mechanisms.
Analysis of CRISPR applications in retinal disease models.
Discussion of CRISPR's potential for targeted nucleotide modification.

Main Results:

CRISPR technology has advanced rapidly for gene therapy applications.
The CRISPR toolkit offers selective targeting of disease-causing mutations.
CRISPR presents a novel therapeutic strategy for inherited retinal diseases.

Conclusions:

CRISPR gene editing holds significant promise for treating inherited retinal diseases.
This technology provides new hope for patients with previously untreatable blinding conditions.
Future applications of CRISPR in ophthalmology are expected to expand.